Antimicrobial Effectiveness Testing (Non-Carrier)

Antimicrobial Science

We run suspension and matrix tests with defined contact times, enumeration methods, and statistical analysis to support R&D, EPA-facing documentation, and formulation decisions.

Purpose & when to use

Antimicrobial Effectiveness (Non-Carrier) testing measures log10 reduction within a bulk product, formulation, gel, slurry, or extractable phase rather than on a fixed hard-surface carrier. ARE Labs plans the controlled inoculation, contact time, neutralization, recovery, and enumeration under ISO 17025 quality controls and aligns the study with ASTM E2315 or applicable EPA registration needs. Use this service when:

ASTM E2315 suspension screening ranks disinfectant formulations, actives, or preservatives before investing in larger EPA registration study matrices.
EPA registration planning for antimicrobial liquids or sprays needs contact-time evidence before moving into carrier or use-site methods.
ISO 17025 quality records are needed to compare gels, slurries, or treated extracts with validated neutralization and recovery controls.
ASTM E1153 aligned recovery logic helps evaluate treated materials when extraction, adsorption, or viscosity could bias survivor counts.
AOAC 961.02 residual narratives need non-carrier screening data before wear, drying, or hard-surface challenge studies are scoped.

Use non-carrier antimicrobial effectiveness testing when the first question is whether a formulation or matrix produces a measurable reduction in the target organisms. The study defines the organism panel, contact time, neutralizer, and recovery workflow before method selection in Section 4.

Formulations and antimicrobial product types served

Non-carrier studies serve products where antimicrobial performance is evaluated in liquid, gel, spray, treated-material extract, or formulation matrix before EPA registration, ASTM, or AOAC-facing work expands.

DisinfectantsBulk liquid actives and blends
SpraysAntimicrobial trigger or aerosol products
GelsViscous products needing recovery checks
Treated materialsExtracts, eluates, and leachables
Industrial productsProcess fluids and additives

Instrumentation & measurement ranges

We select the testing platform based on the organism panel, matrix behavior, endpoint timing, and the claim or screening decision the data need to support.

15 sec – 24 hcontact time

Controlled inoculation and timed-contact workflow

Defined challenge preparation, mixing, exposure timing, temperature control, and endpoint transfer establish the core suspension or matrix-contact conditions for each product.

1 – 10 xdilution series

Neutralizer selection and verification

Candidate neutralizers are checked for antimicrobial stop activity and organism toxicity before efficacy results are interpreted, especially for actives with carryover risk.

1 – 8 LRVreduction

Recovery, dilution, and culture enumeration

Serial dilution, plating, incubation, and colony counting quantify survivors; recovery checks address adsorption, viscosity, soil load, and matrix interference.

20 – 40 Cincubation

Environmental incubation and control logging

Temperature, timing, organism handling, media lots, and incubation conditions are logged for each run so replicate statistics can be traced to protocol conditions.

Test method options

Method	Strengths	Tradeoff	Aligned with
Suspension time-kill effectiveness (ASTM E2315 aligned)	ASTM E2315 supports repeatable formulation ranking across actives and contact times. ISO 17025 controls document inoculum, timing, neutralization, and count calculations.	Suspension results may not predict performance on dried or porous use surfaces.	ASTM E2315ISO 17025
Matrix or gel effectiveness study (EPA registration aligned)	EPA registration planning gains product-specific contact-time data before carrier testing. Validated recovery handles viscosity, adsorption, and active carryover in complex matrices.	Method development expands when product texture interferes with dilution or plating.	EPA registrationISO 17025
Interference and soil-load robustness (ASTM E1153 aligned)	ASTM E1153 recovery logic helps separate product kill from extraction bias. Soils, hard water, or stressors reveal sensitivity before claim studies expand.	Added controls increase sample count and require predefined acceptance criteria.	ASTM E1153ISO 17025
Residual-screening comparison (AOAC 961.02 aligned)	AOAC 961.02 framing informs later residual or wear-study design choices. Side-by-side panels compare actives, binders, and contact times efficiently.	Screening data still needs carrier confirmation for many hard-surface claims.	AOAC 961.02EPA registration

Setup configurations

ARE Labs scopes each non-carrier antimicrobial study around the product matrix, target organisms, contact time, neutralization chemistry, and recovery behavior. Before testing, we define the inoculum target, exposure conditions, soils or interferents, replicate plan, controls, and decision threshold. This ties the resulting log-reduction data to the customer's regulatory or formulation question.

Sample matrix

Liquid, gel, slurry, spray product, treated-material extract, or process fluid documented by active, lot, concentration, and handling conditions.

Exposure profile

Contact times, temperature, organism panel, soil load, hard-water condition, and endpoint transfer sequence fixed before inoculation begins.

Media & handling

Neutralizer, dilution media, plating method, incubation conditions, and matrix blanks selected to avoid antimicrobial carryover or recovery suppression.

Sample numbers

Replicates, untreated controls, neutralizer controls, toxicity controls, growth controls, and matrix blanks sized to the expected reduction target.

Chain of custody

Sample receipt, storage, lot identity, preparation notes, timing records, and deviations documented from intake through final enumeration.

Methods anchored to the standards that matter

These quality markers distinguish the accredited laboratory system from the aligned antimicrobial methods and EPA registration frameworks. Each item matches the accreditation labels shown in the page hero.

ISO 17025AccreditedLaboratory competence, traceability, documented methods, and uncertainty controls.
ASTM E2315AlignedSuspension time-kill method anchor for liquid antimicrobial products.
ASTM E1153AlignedRecovery and carrier-style logic for surface antimicrobial measurements.
EPA registrationAlignedPerformance-substantiation frame for antimicrobial product claims.

Key data outputs & reporting

Non-carrier antimicrobial effectiveness studies report log reduction by organism, matrix, contact time, and test condition. Recovery and neutralization controls are presented alongside the efficacy results to show whether the observed reduction is attributable to product activity rather than antimicrobial carryover, poor extraction, or matrix interference. When the next decision depends on formulation, active level, soil load, or contact time, comparison tables can show those conditions side by side.

Primary outputs

Log10 reduction versus growth or untreated controls for each organism, contact time, matrix, and product condition.
Pass / fail calls against predefined criteria when the protocol includes a decision threshold.
Neutralization effectiveness and toxicity-control summaries documenting whether antimicrobial action stopped at the endpoint.
Recovery validation results for viscous, adsorptive, soil-loaded, or treated-material matrices.
Replicate statistics including mean, SD, CV, and flagged deviations where the design supports comparison.

Deliverables

#	Format	Contents
01	PDF report	Methods, controls, log-reduction tables, QA / QC notes, and interpretation limits.
02	CSV / XLSX datasets	Raw counts, dilution factors, calculations, recovery checks, and replicate statistics.
03	Figures	Time-to-kill curves, organism overlays, and condition comparisons for technical review.

QA / QC & data integrity

Antimicrobial effectiveness data are interpretable only when challenge preparation, contact timing, neutralization, recovery, and enumeration are controlled as one workflow. Each study includes documented controls under the ISO 17025 quality system. ARE Labs reviews the recovery and neutralization evidence before finalizing log-reduction results for screening, comparison, or EPA-facing substantiation.

Growth controls and inoculum confirmations verify the microbial challenge was viable and within the target range.

Neutralization effectiveness and toxicity controls confirm the stop solution works without suppressing organism recovery.

Matrix blanks and contamination checks separate product interference from microbial survival.

Recovery validation documents extraction or dilution performance for viscous, adsorptive, or treated-material matrices.

Replicate calculations report mean, SD, and CV where the design supports quantitative comparison.

Chain-of-custody, timing logs, media lots, and deviations are retained with the final data package.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)

17025Accredited testing

900+Studies Performed

17+Years in operation

300+Clients supported

Common questions

Antimicrobial product teams, treated-material developers, formulation scientists, and consumer-product groups often raise these questions when planning non-carrier effectiveness studies. The answers address EPA-facing use, neutralization, recovery validation, soils, replicates, deliverables, and the transition to carrier methods. They are starting points; contact us if your product matrix, organism panel, or claim path falls outside these examples.

Q.Is this an EPA registration claim test?

A.Non-carrier testing is usually used for screening or substantiation rather than as the final claim test. The data can inform EPA-facing decisions by helping teams select contact times, active levels, or formulations before running carrier-based claim methods.

Q.Why does neutralization matter for antimicrobial testing?

A.Neutralization stops antimicrobial activity at the planned endpoint. Without a demonstrated stop step, surviving organisms may continue to die during dilution or plating, overstating the product's effectiveness at the defined contact time.

Q.Can you test gels, soils, or hard-water conditions?

A.Yes. We can include viscous matrices, soil loads, hard water, or interfering substances when they reflect the product's intended use. Each added condition includes controls for recovery, neutralization, and result interpretation.

Q.How many replicates are typical?

A.The replicate count depends on the expected variability, organism panel, and decision threshold. Studies typically include replicates along with growth controls, neutralizer controls, toxicity controls, and matrix blanks for each major condition.

Q.What do we receive after the study?

A.You receive a PDF report and CSV or XLSX tables containing raw counts, dilution factors, calculations, control results, recovery data, and log10 reductions. Figures can present time-to-kill curves or comparisons across test conditions.

Standards & guidance

ARE Labs plans antimicrobial effectiveness studies around laboratory competence, suspension time-kill methods, carrier-style recovery logic, residual-use context, and EPA registration performance expectations. ISO 17025 serves as the accredited laboratory anchor. ASTM E2315, ASTM E1153, AOAC 961.02, and EPA registration provide aligned frameworks when supported by the product, matrix, and proposed claim language.

QA & Regulatory - Accredited

Related services & devices

Service